Prime pharmacists address AMCP virtual conference as keynote speakers

Catherine Starner, PharmD and Nicole Kjesbo, PharmD discuss the specialty drug pipeline and forecast

April 23, 2021
The specialty pharmaceutical market continues to grow at an outstanding rate offering new treatment options and the promise of improved outcomes. Prime pharmacists Catherine Starner, PharmD and Nicole Kjesbo, Pharm D, took a deep dive into a select number of potential high cost, high uptake specialty drugs as keynote speakers at the spring 2021 virtual Academy of Managed Care Pharmacy (AMCP) conference in front of an online crowd of approximately 600 attendees.

To determine the pipeline and forecast, Starner and Kjesbo consider cost, population/prevalence and management strategies – such as utilization management, prior authorizations and quantity limits. For inclusion on the Watch List, Prime generally focuses on drugs that are submitted to the U.S. Food and Drug Administration (FDA) and have a high anticipated spend based on per member per month (PMPM). Prime forecasts drugs on both medical and pharmacy benefits to help manage total drug spend for its health plan clients.

Starner and Kjesbo focused on pipeline and forecasting for:

While gene therapy approvals have been few and far between, there are more on the horizon. Possible gene therapy reviews include:

  • Eladocagene exuparvovec, PTC Therapeutics – aromatic l-amino acid decarboxylase (AADC) deficiency
  • SRP-9001, Sarepta Therapeutics – Duchenne muscular dystrophy (DMD)
  • AMT-061 (etranacogene dezaparvovec), uniQure – hemophilia B

Prime publishes monthly decisions expected from the FDA and monthly pipelines.

Related news

Stories

April 5, 2024

LISTEN NOW: Revolutionizing Healthcare: Prime & Capital Rx’s Game-Changing Alliance – Pharmacy Friends podcast

In this special episode of the Pharmacy Friends podcast, the CEOs of Prime Therapeutics, Mostafa Kamal, and Capital Rx, AJ Loiacono, join Michael Passanante, SVP of Marketing & Communications at Capital Rx, to share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy.

Stories

March 26, 2024

Announcing the new issue of Prime’s managed care report, featuring the latest trends and updates in medical and pharmacy benefits

Prime Therapeutics/Magellan Rx (Prime/MRx) today launched the spring edition of Magellan Rx Report…

Stories

March 19, 2024

Healthcare Businesswomen’s Association names Simone Ndujiuba and Jacki Shugart among 2024 Rising Stars 

Prime Therapeutics/Magellan Rx’s Director of Clinical Strategy and Innovation Simone Ndujiuba and Senior Program Manager Jacki Shugart honored for female leadership in the health care industry